BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 9119)

  • 1. A summary of biochemical changes and the pathogenesis of liver coma.
    Santiago Delpin EA
    Bol Asoc Med P R; 1976 Aug; 68(8):205-10. PubMed ID: 9119
    [No Abstract]   [Full Text] [Related]  

  • 2. [Pathogenesis of hepatic coma].
    Capocaccia L; Rossi Fanelli F; Cascino A; Cangiano C; Calcaterra V; de Conciliis D; Gentile S; Merli M; Riggio O; Stortoni M; Giunchi G
    Recenti Prog Med; 1981 Apr; 70(4):358-99. PubMed ID: 6114522
    [No Abstract]   [Full Text] [Related]  

  • 3. Cerebral amino acid metabolism in hepatic coma.
    Berl S
    Exp Biol Med; 1971; 4():71-84. PubMed ID: 5162461
    [No Abstract]   [Full Text] [Related]  

  • 4. [Changes in brain metabolism in hepatic coma].
    Funovics JM; Dedrick DF; Fischer JE; Biebuyck JE
    Chir Forum Exp Klin Forsch; 1977 Apr; ():171-5. PubMed ID: 36264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathogenesis and therapy of hepatic coma.
    Fischer JE; Baldessarini RJ
    Prog Liver Dis; 1976; 5():363-97. PubMed ID: 5747
    [No Abstract]   [Full Text] [Related]  

  • 6. Cerebral ammonia metabolism and hepatic coma.
    Summerskill WH
    Exp Biol Med; 1971; 4():85-91. PubMed ID: 5162462
    [No Abstract]   [Full Text] [Related]  

  • 7. The enigma of hepatic encephalopathy.
    Jones EA
    Postgrad Med J; 1983; 59 Suppl 4():42-54. PubMed ID: 6139803
    [No Abstract]   [Full Text] [Related]  

  • 8. [Metabolic principles in hepatic encephalopathy].
    Gerok W
    Internist (Berl); 1985 Jul; 26(7):377-87. PubMed ID: 2863233
    [No Abstract]   [Full Text] [Related]  

  • 9. Reversible modifications of neurotransmitters of the brain in experimental acute hepatic coma.
    Bloch P; Delorme ML; Rapin JR; Granger A; Boschat M; Opolon P
    Surg Gynecol Obstet; 1978 Apr; 146(4):551-8. PubMed ID: 24900
    [No Abstract]   [Full Text] [Related]  

  • 10. [Ammonia and GABA-ergic neurotransmission in pathogenesis of hepatic encephalopathy].
    Helewski K; Kowalczyk-Ziomek G; Konecki J
    Wiad Lek; 2003; 56(11-12):560-3. PubMed ID: 15058165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-ketoglutarmate, glutamate antagonism and GABA depletion--clues to the pathogenesis of hepatic encephalopathy?
    Kardel T; Gips CH
    Neth J Med; 1974; 17(2):37-41. PubMed ID: 4839372
    [No Abstract]   [Full Text] [Related]  

  • 12. [Pathogenesis of portal systemic encephalopathy].
    García Compeán D; Valadez Castillo R; Barragán RF
    Rev Invest Clin; 1990 Jul; 42 Suppl():113-9. PubMed ID: 19256149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Metabolic disorders in hepatic encephalopathy].
    Albrecht J
    Neuropatol Pol; 1984; 22(4):499-508. PubMed ID: 6152488
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathogenesis of hepatic encephalopathy--studies in the rabbit model of acute liver failure].
    Jones EA; Ferenci P; Pappas SC; Schafer DF
    Leber Magen Darm; 1984 Nov; 14(6):282-7. PubMed ID: 6151107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain monoamines in hepatic encephalopathy and other types of metabolic coma.
    Jellinger K; Riederer P; Rausch WD; Kothbauer P
    J Neural Transm Suppl; 1978; (14):103-20. PubMed ID: 39973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hepatic coma. Basic principles of pathogenesis and treatment. 1. Pathogenesis].
    Müting D; Reikowski J
    Fortschr Med; 1983 Sep; 101(36):1610-4. PubMed ID: 6605291
    [No Abstract]   [Full Text] [Related]  

  • 17. Brain energy metabolism and alterations of transmitter profiles in acute hepatic coma.
    Funovics JM; Fischer JE
    J Neural Transm Suppl; 1978; (14):61-7. PubMed ID: 290741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic encephalopathy and the neural regulation of hypothalamic pituitary function.
    Van Thiel DH; Gavaler JS; Tarter R; Schade RR; Stone BG
    Semin Liver Dis; 1985 Feb; 5(1):70-83. PubMed ID: 2858919
    [No Abstract]   [Full Text] [Related]  

  • 19. [Effect of differentiated diet therapy on the clinical results and biochemical indicators in chronic hepatic encephalopathy].
    Szpakowicz T; Boroń P; Flisiak R; Bobrowska E; Kaczmarska A; Nowak HF; Zimnoch L
    Przegl Lek; 1990; 47(7):527-31. PubMed ID: 2284419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Changes in and modulation of receptor activity in hepatic encephalopathy].
    Kienzl E; Riederer P; Brücke T; Kleinberger G; Jellinger K
    Infusionsther Klin Ernahr; 1985 Feb; 12(1):32, 37-45. PubMed ID: 2859245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.